Mitochondrial Homeostasis: Auto-regulation in the powerhouse

Mitochondrial flashes have a central role in ensuring that ATP levels remain constant in heart cells.
  1. Helena M Viola
  2. Livia C Hool  Is a corresponding author
  1. The University of Western Australia, Australia
  2. Victor Chang Cardiac Research Institute, Australia

Adenosine triphosphate, or ATP for short, provides the energy that is needed for countless processes in the body. It is vital that the level of ATP in cells remains constant, especially when the demand for energy increases. This is particularly true in the heart, where energy demand can increase by a factor of 5–10 during stressful situations, yet the ATP concentration remains remarkably consistent (Balaban et al., 1986; Neely et al., 1973; Matthews et al., 1981; Allue et al., 1996).

Despite decades of research, it has remained unclear how cells keep their ATP levels stable. Now, in eLife, Heping Cheng of Peking University and colleagues – with Xianhua Wang, Xing Zhang and Di Wu as joint first authors – report that a process termed mitochondrial flash or mitoflash plays a critical role in regulating ATP concentration in the heart (Wang et al., 2017).

ATP production occurs in several stages inside mitochondria, where a flow of electrons down the mitochondrial ‘electron transport chain’ creates an electro-chemical gradient across the inner membrane of mitochondria. In the first stage, calcium is transported across the inner membrane into the inner mitochondrial chamber or matrix, and used in a process known as the citric acid cycle to generate high-energy electrons. These electrons then enter the electron transport chain and travel along the inner membrane to an enzyme called ATP-synthase that produces ATP. As a by-product of this process, molecules called reactive oxygen species are formed when electrons that leak from the electron transport chain go on to react with oxygen molecules. Although high levels of reactive oxygen species lead to cell death and disease, low levels of these species are important for regulating normal cell processes.

Recent research has shown that mitochondria exhibit brief events called mitoflashes. These involve multiple concurrent changes within the mitochondria, including a burst in the production of reactive oxygen species, as well as changes in the pH of the mitochondrial matrix, the oxidative redox state and the membrane potential (Wang et al., 2008, 2016). Mitoflashes depend on an intact electron transport chain and are thought to help regulate energy metabolism.

Using cells isolated from mouse heart muscle, Wang et al. demonstrated that it is the frequency of the mitoflashes – rather than the amplitude – that regulates ATP production. When the heart cells were exposed to drivers of the citric acid cycle to mimic increased energy metabolism, the mitoflashes occurred more frequently, while ATP production remained constant. However, when antioxidants were applied, the frequency of mitoflashes decreased, which led to an increase in ATP production. These findings suggest that mitoflash activity responds to changes in energy metabolism to negatively regulate ATP production.

When electrical stimuli were applied to make the heart cells contract more quickly and increase the demand for ATP, the frequency of mitoflashes decreased, while the cellular ATP content remained constant. It appears that when a lot of energy is needed, changes in the frequency of the mitoflashes regulate ATP production in a way that supports survival. Indeed, the results revealed that when mitoflash frequency decreased, the ATP concentration or set-point increased. This suggests that mitoflash activity may act as an ATP set-point regulator that responds to changes in energy supply and demand in order to maintain ATP homeostasis in the heart (see Figure 6 in Wang et al., 2017).

Wang et al. provide the first mechanistic insight into a potential trigger that links changes in mitoflash frequency and regulation of the ATP set-point in the heart. Previous studies have identified three possible triggers of mitoflashes: calcium located in the mitochondrial matrix, reactive oxygen species and protons (Hou et al., 2013; Wang et al., 2016). Wang et al. propose that calcium is unlikely to play a significant role in the regulation of mitoflash frequency. And since electrical stimulation did not significantly change the amount of reactive oxygen species produced by the mitochondria, they focused their attention on protons as a trigger of mitoflashes.

It is known that protons can leak through the ATP-synthase and return to the mitochondrial matrix, and it has been shown that a pro-survival protein called Bcl-xL plays a role in regulating this proton leak (Alavian et al., 2011; Chen et al., 2011). Now, Wang et al. show that an increase in Bcl-xL prevents proton leaks and reduces the frequency of mitoflashes, while the ATP set-point increases. When there is a decrease in Bcl-xL protein, the opposite occurs. Based on these findings, Wang et al. propose that proton leaks may be a bi-directional trigger of mitoflashes and cellular ATP homeostasis.

Overall, Wang et al. demonstrate that mitoflash frequency negatively regulates ATP production in a compensatory, pro-survival manner, and that a high ATP demand induces a small and brief increase in calcium. These results are consistent with previous work characterizing mitoflashes (Wang et al., 2008) and the role of mitochondria in the development of diseases in the heart (Viola et al., 2007; Seenarain et al., 2010). Future studies may provide more insight into how mitoflashes regulate ATP homeostasis during the development of heart diseases.

References

    1. Neely JR
    2. Rovetto MJ
    3. Whitmer JT
    4. Morgan HE
    (1973)
    Effects of ischemia on function and metabolism of the isolated working rat heart
    The American Journal of Physiology 225:651–658.

Article and author information

Author details

  1. Helena M Viola

    School of Human Sciences, The University of Western Australia, Crawley, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Livia C Hool

    1. School of Human Sciences, The University of Western Australia, Crawley, Australia
    2. Victor Chang Cardiac Research Institute, Sydney, Australia
    For correspondence
    livia.hool@uwa.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7758-5252

Publication history

  1. Version of Record published:

Copyright

© 2017, Viola et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,870
    views
  • 194
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Helena M Viola
  2. Livia C Hool
(2017)
Mitochondrial Homeostasis: Auto-regulation in the powerhouse
eLife 6:e28757.
https://doi.org/10.7554/eLife.28757
  1. Further reading

Further reading

    1. Cell Biology
    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology
    Yan Song, Linda J Fothergill ... Gene W Yeo
    Research Article

    Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.